Calcium stones make up 70–80% of cases; uric acid stones and struvite stones account for 10–15% each, and cystine stones for under 1%.
Nephrolithiasis: A Comprehensive Review of Pathophysiology, Clinical Presentation, and Management
S. B Bothra, Shahajan Shabbir Baig, Barrawaz Aateka Yahya
- Editor approved · 16 Nov 2026
- June 2026
- DOI 10.56511/jipbs.2026.13110
The question
How common are kidney stones, how are they found, and what is used to treat and prevent them?
- About 12% of people worldwide are affected, and the share is rising alongside obesity, metabolic syndrome and diet.
- Typical signs are severe colicky pain, hematuria and signs in the urinary tract, though some cases stay silent.
What was done
- The article sets out how stones arise, how patients present, how the disease is diagnosed, and how it is treated and prevented.
- Stone formation is described as a chain of physicochemical steps — supersaturation, then nucleation, growth of crystals and their retention — with Randall's plaque as a critical site for nucleation.
- Treatment has moved away from open surgery towards minimally invasive methods: shock wave lithotripsy, percutaneous nephrolithotomy and ureteroscopy.
- Alpha-blockers, given as medical expulsive therapy, help ureteral stones of 5 mm or less to pass on their own.
Key findings
Non-contrast helical CT is named the diagnostic gold standard, with a sensitivity of 98%.
Alpha-blockers given as medical expulsive therapy ease the spontaneous passage of ureteral stones of 5 mm or less.
A recurrence rate of 50% is observed within 5 to 10 years; the authors say that grasping these many factors allows treatment fitted to the individual and lowers that rate.
Why it matters
- Prevention rests on drinking at least 2 L a day, keeping calcium intake normal while cutting sodium, and medicines such as thiazide diuretics or potassium citrate chosen by stone type and metabolic findings.
- Strong associations are reported between the parts of metabolic syndrome — obesity, diabetes, hypertension, dyslipidemia — and a raised risk of stones, so the authors stress metabolic assessment and changes in daily life.
How to cite
S. B Bothra, Shahajan Shabbir Baig, Barrawaz Aateka Yahya. Nephrolithiasis: A Comprehensive Review of Pathophysiology, Clinical Presentation, and Management. Journal of Innovations in Pharmaceutical and Biological Sciences. 2026;13(01):83-95. https://doi.org/10.56511/jipbs.2026.13110
- The article at doi.org (the publisher's page and PDF)
- The article on the journal's site
- The journal at the ISSN Portal (ISSN 2349-2759)